| (Values in U.S. Thousands) | Jun, 2026 | Mar, 2026 | Dec, 2025 | Sep, 2025 | Jun, 2025 |
| Sales | 109,450 | 108,390 | 96,050 | 83,520 | 66,570 |
| Sales Growth | +0.98% | +12.85% | +15.00% | +25.46% | +12.91% |
| Net Income | 8,050 | 17,970 | 4,420 | 5,710 | -250 |
| Net Income Growth | -55.20% | +306.56% | -22.59% | +2,384.00% | +93.73% |
Billiontoone Inc Cl A (BLLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
BillionToOne Inc. is a molecular diagnostics company. BillionToOne Inc. is based in headquartered in Menlo Park, California.
Fiscal Year End Date: 12/31